2Peker S,Akar N,Demiralp D O.Proteomic identification of erythrocyte membrane protein deficiency in hereditary spherocytosis[J].Mol Bio Rep,2012,39(3):3161-3167.
3Bolton Maggs P H,Langer J C,Iolascon A,et al.Guidelines for the diagnosis and management of hereditary spherocytosis:2011 update[J].Br J Haematol,2012,156(1):37-49.
4Bader Meunier B,Gauthier F,Archambaud F,et al.Long-term evaluation of the beneficial effect of subtotal splenectomy for management of hereditary spherocytosis.[J].Blood,2001,97(2):399-403.
5Kimura F,Ito H,Shimizu H,et al.Partial splenic embolization for the treatment of hereditary spherocytosis[J].AJRAmJ Roentgenol,2003,181(4):1021-1024.
6Chen W,Zhang X,Shang X,et al.The molecular basis of beta-thalassemia intermedia in southern China:genotypic heterogeneity and phenotypic diversity[J]BMC Med Genet,2010,11:31.
7Puthenveetil G,Scholes J,Carbonell D,et al.Successful correction of the human beta-thalassemia major phenotype using a lentiviral vector[J].Blood,2004,104(12):3445-3453.
8Akar N,Gokce H.Red blood cell indexes in patients in patients with hereditary spherocytosis and beta-thalassemia combination[J].Pediatr Hematol Oncol,2002,19(8):569-573.
